{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:28:46Z","timestamp":1790832526411,"version":"4.1.0"},"reference-count":106,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010506","name":"Indiana University Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010506","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01626","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T14:38:32Z","timestamp":1593182312000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":180,"title":["Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19"],"prefix":"10.3389","volume":"11","author":[{"given":"Rafael B.","family":"Polidoro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Hagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"de Santis Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan W.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,6,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.20.048066","article-title":"Shotgun transcriptome and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions","author":"Butler","year":"2020","journal-title":"bioRxiv [preprint]."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.05.079194","article-title":"Bulk and single-cell gene expression profiling of SARS-CoV-2 infected human cell lines identifies molecular targets for therapeutic intervention","author":"Wyler","year":"2020","journal-title":"bioRxiv [preprint]."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","article-title":"SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues","volume":"181","author":"Ziegler","year":"2020","journal-title":"Cell"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1128\/JVI.01248-09","article-title":"Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63","volume":"84","author":"Glowacka","year":"2010","journal-title":"J Virol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1113\/expphysiol.2007.040048","article-title":"The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice","volume":"93","author":"Imai","year":"2008","journal-title":"Exp Physiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/SHK.0000000000000633","article-title":"Pulmonary angiotensin-converting enzyme 2 (ACE2) and inflammatory lung disease","volume":"46","author":"Jia","year":"2016","journal-title":"Shock."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.34172\/jrip.2020.19","article-title":"COVID-19 interactions with angiotensin-converting enzyme 2 (ACE2) and the kinin system; looking at a potential treatment","volume":"9","author":"Tolouian","year":"2020","journal-title":"J Renal Injury Prevent."},{"key":"B11","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1152\/ajpregu.00535.2002","article-title":"The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction","volume":"285","author":"Schmaier","year":"2003","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1093\/cid\/ciu924","article-title":"Validation of the wild-type influenza A human challenge model H1N1pdMIST: an A(H1N1)pdm09 dose-finding investigational new drug study","volume":"60","author":"Memoli","year":"2015","journal-title":"Clin Infect Dis."},{"key":"B13","unstructured":"The early phase of the COVID-19 outbreak in Lombardy, Italy\n            CeredaD\n            TiraniM\n            RovidaF\n            DemicheliV\n            AjelliM\n            PolettiP\n          32362647arXiv2020"},{"key":"B14","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41591-020-0869-5","article-title":"Temporal dynamics in viral shedding and transmissibility of COVID-19","volume":"26","author":"He","year":"2020","journal-title":"Nat Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/S1473-3099(20)30232-2","article-title":"Viral dynamics in mild and severe cases of COVID-19","volume":"20","author":"Liu","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s13054-020-02893-8","article-title":"SARS-CoV-2 viral load in sputum correlates with risk of COVID-19 progression","volume":"24","author":"Yu","year":"2020","journal-title":"Crit Care."},{"key":"B17","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.chom.2020.04.009","article-title":"Complex immune dysregulation in COVID-19 patients with severe respiratory failure","volume":"27","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell Host Microbe"},{"key":"B18","doi-asserted-by":"publisher","first-page":"105954","DOI":"10.1126\/science.abb8925","article-title":"Cytokine release syndrome in severe COVID-19","volume":"55","author":"Moore","year":"2020","journal-title":"Science"},{"key":"B19","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.healun.2020.03.012","article-title":"COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal","volume":"39","author":"Siddiqi","year":"2020","journal-title":"J Heart Lung Transpl"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/art.41285","article-title":"On the alert for cytokine storm: immunopathology in COVID-19","author":"Henderson","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","article-title":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology","volume":"39","author":"Channappanavar","year":"2017","journal-title":"Semin Immunopathol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1146\/annurev-med-051215-031152","article-title":"Middle east respiratory syndrome: emergence of a pathogenic human Coronavirus","volume":"68","author":"Fehr","year":"2017","journal-title":"Annu Rev Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J Clin Invest"},{"key":"B24","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1126\/science.368.6489.356","article-title":"A rampage through the body","volume":"368","author":"Wadman","year":"2020","journal-title":"Science"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.5772\/57392","article-title":"Nature and consequences of the systemic inflammatory response induced by lung inflammation","author":"Hiraiwa","year":"2014","journal-title":"IntechOpen"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1164\/rccm.202004-1076ED","article-title":"Basing respiratory management of coronavirus on physiological principles","volume":"201","author":"Tobin","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13054-020-02880-z","article-title":"COVID-19 pneumonia: ARDS or not?","volume":"24","author":"Gattinoni","year":"2020","journal-title":"Crit Care."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1164\/rccm.202003-0817LE","article-title":"Covid-19 does not lead to a \u201ctypical\u201d acute respiratory distress syndrome","volume":"201","author":"Gattinoni","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1164\/rccm.201605-1081CP","article-title":"Mechanical ventilation to minimize progression of lung injury in acute respiratory failure","volume":"195","author":"Brochard","year":"2017","journal-title":"Am J Respir Crit Care Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1056\/NEJMra1208707","article-title":"Ventilator-induced lung injury","volume":"369","author":"Slutsky","year":"2013","journal-title":"N Engl J Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"key":"B33","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41591-020-0868-6","article-title":"SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes","volume":"26","author":"Sungnak","year":"2020","journal-title":"Nat Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1126\/science.367.6485.1412","article-title":"Race to find COVID-19 treatments accelerates","volume":"367","author":"Kupferschmidt","year":"2020","journal-title":"Science."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.29.20084327","article-title":"Cross-talk between the airway epithelium and activated immune cells defines severity in COVID-19","author":"Chua","year":"2020","journal-title":"medRxiv [preprint]."},{"key":"B37","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1080\/22221751.2020.1747363","article-title":"Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients","volume":"9","author":"Xiong","year":"2020","journal-title":"Emerg Microbes Infect."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1164\/rccm.200909-1427SO","article-title":"Innate immune recognition in infectious and noninfectious diseases of the lung","volume":"181","author":"Opitz","year":"2010","journal-title":"Am J Respir Crit Care Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41591-020-0901-9","article-title":"Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19","volume":"26","author":"Liao","year":"2020","journal-title":"Nat Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.3541136","article-title":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China","author":"Qin","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1172\/JCI116351","article-title":"Tumor necrosis factor-alpha blockade prevents neutrophil CD18 receptor upregulation and attenuates acute lung injury in porcine sepsis without inhibition of neutrophil oxygen radical generation","volume":"91","author":"Windsor","year":"1993","journal-title":"J Clin Invest."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e20200652","DOI":"10.1084\/jem.20200652","article-title":"Targeting potential drivers of COVID-19: neutrophil extracellular traps","volume":"217","author":"Barnes","year":"2020","journal-title":"J Exp Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e138999","DOI":"10.1172\/jci.insight.138999","article-title":"Neutrophil extracellular traps in COVID-19","volume":"5","author":"Zuo","year":"2020","journal-title":"JCI Insight."},{"key":"B44","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","article-title":"Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages","volume":"20","author":"Merad","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1165\/ajrcmb.27.1.4787","article-title":"Interaction of alveolar macrophages and airway epithelial cells following exposure to particulate matter produces mediators that stimulate the bone marrow","volume":"27","author":"Fujii","year":"2002","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-phase proteins and other systemic responses to inflammation","volume":"340","author":"Gabay","year":"1999","journal-title":"N Engl J Med."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14854","article-title":"The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome","author":"Ranucci","year":"2020","journal-title":"J Thromb Haemost"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/jth.14817","article-title":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/all.14238","article-title":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China","author":"Zhang","year":"2020","journal-title":"Allergy"},{"key":"B50","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/v8070184","article-title":"Regulation of stress responses and translational control by coronavirus","volume":"8","author":"Fung","year":"2016","journal-title":"Viruses."},{"key":"B51","doi-asserted-by":"publisher","first-page":"3105817","DOI":"10.1155\/2019\/3105817","article-title":"Endothelial protein c receptor could contribute to experimental malaria-associated acute respiratory distress syndrome","volume":"2019","author":"Dos Santos Ortolan","year":"2019","journal-title":"J Immunol Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S1473-3099(20)30200-0","article-title":"Clinical and virological data of the first cases of COVID-19 in Europe: a case series","volume":"20","author":"Lescure","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30434-5","article-title":"Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study","author":"Carsana","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1111\/jth.14844","article-title":"Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19","volume":"18","author":"Dolhnikoff","year":"2020","journal-title":"J Thromb Haemost"},{"key":"B55","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.regpep.2006.11.018","article-title":"Leptin deficiency leads to the regulation of kinin receptors expression in mice","volume":"138","author":"Abe","year":"2007","journal-title":"Regul Pept."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e40573","DOI":"10.1371\/journal.pone.0040573","article-title":"Altered glucose homeostasis and hepatic function in obese mice deficient for both kinin receptor genes","volume":"7","author":"Barros","year":"2012","journal-title":"PLoS ONE."},{"key":"B58","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1467-789X.2011.00942.x","article-title":"The renin-angiotensin system: a link between obesity, inflammation and insulin resistance","volume":"13","author":"Kalupahana","year":"2012","journal-title":"Obes Rev."},{"key":"B59","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/MNH.0000000000000344","article-title":"The kallikrein-kinin system in diabetic kidney disease","volume":"26","author":"Liu","year":"2017","journal-title":"Curr Opin Nephrol Hypertens."},{"key":"B60","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/2047-783X-15-S2-120","article-title":"Proinflammatory cytokines Il-6 and TNF-alpha and the development of inflammation in obese subjects","volume":"15","author":"Popko","year":"2010","journal-title":"Eur J Med Res."},{"key":"B61","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1002\/cphy.c100053","article-title":"The kallikrein-kinin system as a regulator of cardiovascular and renal function","volume":"1","author":"Rhaleb","year":"2011","journal-title":"Compr Physiol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"787","DOI":"10.2147\/VHRM.S1905","article-title":"The renin-angiotensin system and diabetes: an update","volume":"4","author":"Ribeiro-Oliveira","year":"2008","journal-title":"Vasc Health Risk Manag."},{"key":"B63","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3233\/NHA-160021","article-title":"Ras signaling in aging and metabolic regulation","volume":"4","author":"Slack","year":"2017","journal-title":"Nutr Healthy Aging."},{"key":"B64","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2174\/156720511794604570","article-title":"Kallikrein-kinin system mediated inflammation in Alzheimers disease in vivo","volume":"8","author":"Viel","year":"2011","journal-title":"Curr Alzheimer Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"102180","DOI":"10.1016\/j.msard.2020.102180","article-title":"Severe COVID-19 infection in a patient with multiple sclerosis treated with fingolimod","volume":"42","author":"Foerch","year":"2020","journal-title":"Mult Scler Relat Disord."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1111\/odi.12908","article-title":"Alteration of macrophage viability, differentiation, and function by bisphosphonates","volume":"24","author":"Patntirapong","year":"2018","journal-title":"Oral Dis."},{"key":"B67","doi-asserted-by":"publisher","first-page":"e90720","DOI":"10.1371\/journal.pone.0090720","article-title":"Depletion of alveolar macrophages ameliorates virus-induced disease following a pulmonary coronavirus infection","volume":"9","author":"Hartwig","year":"2014","journal-title":"PLoS ONE."},{"key":"B68","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1172\/JCI97229","article-title":"Microglia are required for protection against lethal coronavirus encephalitis in mice","volume":"128","author":"Wheeler","year":"2018","journal-title":"J Clin Invest."},{"key":"B69","doi-asserted-by":"publisher","first-page":"10175","DOI":"10.1038\/s41598-018-28490-y","article-title":"The small molecule drug diminazene aceturate inhibits liver injury and biliary fibrosis in mice","volume":"8","author":"Rajapaksha","year":"2018","journal-title":"Sci Rep."},{"key":"B70","doi-asserted-by":"publisher","first-page":"175","DOI":"10.13294\/j.aps.2018.0029","article-title":"ACE2 agonist DIZE alleviates lung injury induced by limb ischemia-reperfusion in mice","volume":"70","author":"Li","year":"2018","journal-title":"Sheng Li Xue Bao."},{"key":"B71","unstructured":"2020"},{"key":"B72","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ctrv.2016.09.013","article-title":"Bone-targeted therapy use in patients with bone metastases from lung cancer: a systematic review of randomized controlled trials","volume":"50","author":"LeVasseur","year":"2016","journal-title":"Cancer Treat Rev."},{"key":"B73","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13054-017-1823-x","article-title":"A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome","volume":"21","author":"Khan","year":"2017","journal-title":"Crit Care."},{"key":"B74","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","article-title":"Virological assessment of hospitalized patients with COVID-2019","volume":"581","author":"Wolfel","year":"2020","journal-title":"Nature"},{"key":"B75","doi-asserted-by":"publisher","first-page":"105954","DOI":"10.1016\/j.ijantimicag.2020.105954","article-title":"The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist tocilizumab may be the key to reduce the mortality","volume":"55","author":"Zhang","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"B76","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1002\/art.38802","article-title":"Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients","volume":"66","author":"Minoia","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1056\/NEJMc2008597","article-title":"Neurologic Features in Severe SARS-CoV-2 Infection","volume":"382","author":"Helms","year":"2020","journal-title":"N Engl J Med"},{"key":"B78","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1002\/ajh.25793","article-title":"Leukoerythroblastic reaction in a patient with COVID-19 infection","volume":"35","author":"Mitra","year":"2020","journal-title":"Am J Hematol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2020.05.017","article-title":"Crucial laboratory parameters in COVID-19 diagnosis and prognosis: an updated meta-analysis","author":"Soraya","year":"2020","journal-title":"Med Clin."},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0944-y","article-title":"A single-cell atlas of the peripheral immune response in patients with severe COVID-19","author":"Wilk","year":"2020","journal-title":"Nat Med"},{"key":"B81","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1161\/ATVBAHA.109.200956","article-title":"Cellular mechanisms underlying the formation of circulating microparticles","volume":"31","author":"Morel","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1056\/NEJMc2009787","article-title":"Large-vessel stroke as a presenting feature of covid-19 in the Young","volume":"382","author":"Oxley","year":"2020","journal-title":"N Engl J Med"},{"key":"B83","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.3389\/fimmu.2019.03150","article-title":"Crucial Involvement of IL-6 in thrombus resolution in mice via macrophage recruitment and the induction of proteolytic enzymes","volume":"10","author":"Nosaka","year":"2019","journal-title":"Front Immunol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2147\/ITT.S202015","article-title":"Cytokine release syndrome: current perspectives","volume":"8","author":"Murthy","year":"2019","journal-title":"Immunotargets Ther."},{"key":"B85","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ejim.2020.05.009","article-title":"Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia","volume":"76","author":"Capra","year":"2020","journal-title":"Eur J Intern Med."},{"key":"B86","unstructured":"Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-1952932\n            SciasciaS\n            ApraF\n            BaffaA\n            BaldovinoS\n            BoaroD\n            BoeroR\n          32359035Clin Exp Rheumatol.382020"},{"key":"B87","doi-asserted-by":"publisher","first-page":"102568","DOI":"10.1016\/j.autrev.2020.102568","article-title":"Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy","volume":"19","author":"Toniati","year":"2020","journal-title":"Autoimmun Rev."},{"key":"B88","doi-asserted-by":"publisher","first-page":"10970","DOI":"10.1073\/pnas.2005615117","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"117","author":"Xu","year":"2020","journal-title":"Proc Natl Acad Sci USA."},{"key":"B89","unstructured":"Early tocilizumab treatment could improve survival among COVID-19 patients578\n            CampinsL\n            BoixedaR\n            Perez-CordonL\n            AranegaR\n            LoperaC\n            ForceL\n          32456769Clin Exp Rheumatol.382020"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217706","article-title":"Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series","author":"Aouba","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B91","doi-asserted-by":"publisher","first-page":"e325","DOI":"10.1016\/S2665-9913(20)30127-2","article-title":"Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study","volume":"2","author":"Cavalli","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2020.05.007","article-title":"Favorable anakinra responses in severe covid-19 patients with secondary hemophagocytic lymphohistiocytosis","author":"Dimopoulos","year":"2020","journal-title":"Cell Host Microbe"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(20)30164-8","article-title":"Anakinra for severe forms of COVID-19: a cohort study","author":"Huet","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.05.002","article-title":"Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease","author":"Pontali","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost."},{"key":"B96","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1016\/S2213-2600(20)30110-7","article-title":"Respiratory support for patients with COVID-19 infection","volume":"8","author":"Namendys-Silva","year":"2020","journal-title":"Lancet Respir Med."},{"key":"B97","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/angiotensin-(1-7)\/MAS axis of the renin-angiotensin system: focus on angiotensin-(1-7)","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol Rev."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.3390\/ijms18061294","article-title":"Age-related changes in immunological and physiological responses following pulmonary challenge","volume":"18","author":"Miller","year":"2017","journal-title":"Int J Mol Sci."},{"key":"B99","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.3389\/fimmu.2019.02806","article-title":"BCG-induced cross-protection and development of trained immunity: implication for vaccine design","volume":"10","author":"Covian","year":"2019","journal-title":"Front Immunol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"e016219","DOI":"10.1161\/JAHA.120.016219","article-title":"Coronavirus disease 2019 (COVID-19) and cardiovascular disease: a viewpoint on the potential influence of angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers on onset and severity of severe acute respiratory syndrome coronavirus 2 infection","volume":"9","author":"Guo","year":"2020","journal-title":"J Am Heart Assoc."},{"key":"B101","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","volume":"63","author":"Liu","year":"2020","journal-title":"Sci China Life Sci."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1164\/rccm.200204-302OC","article-title":"Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis","volume":"166","author":"Eichacker","year":"2002","journal-title":"Am J Respir Crit Care Med."},{"key":"B103","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1164\/rccm.200607-995OC","article-title":"The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease","volume":"175","author":"Rennard","year":"2007","journal-title":"Am J Respir Crit Care Med."},{"key":"B104","doi-asserted-by":"publisher","first-page":"e00398","DOI":"10.1128\/mBio.00398-20","article-title":"Hiding in plain sight: an approach to treating patients with severe COVID-19 infection","volume":"11","author":"Fedson","year":"2020","journal-title":"mBio."},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe covid-19","author":"Cao","year":"2020","journal-title":"N Engl J Med"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/S0140-6736(20)31042-4","article-title":"Triple combination of interferon beta-1b, lopinavir\u2013ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial","volume":"395","author":"Hung","year":"2020","journal-title":"Lancet"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01626\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T14:38:37Z","timestamp":1593182317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01626\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,26]]},"references-count":106,"alternative-id":["10.3389\/fimmu.2020.01626"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01626","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,26]]},"article-number":"1626"}}